Abstract
SummaryPentazocine does not cause the hypotension associated with the use of opiates in patients with myocardial infarction but some haemodynamic studies have suggested that the drug could be hazardous. An analysis is described of 457 consecutive patients admitted to a Coronary Care Unit, of whom 250 (55%) received pentazocine for relief of chest pain, while the remainder did not require analgesics and, therefore, acted as a control.Utilising a coronary prognostic index no significant difference in the mortality rate between the two groups was demonstrated, nor was the mortality dependent on the total dosage. Furthermore, no clinical disadvantage arose from the administration of pentazocine to patients with elevated systolic blood pressure on admission.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
